OYST - Oyster Point Pharma Inc. (OYST) CEO Jeffrey Nau on Q2 2021 Results - Earnings Call Transcript
Oyster Point Pharma, Inc. (OYST) Q2 2021 Earnings Conference Call August 05, 2021 04:30 PM ET Company Participants Daniel Lochner - Chief Financial Officer Jeffrey Nau - President and Chief Executive Officer John Snisarenko - Chief Commercial Officer Conference Call Participants Stacy Ku - Cowen and Company Anupam Rama - JPMorgan Joe Catanzaro - Piper Sandler Patrick Dolezal - LifeSci Capital Presentation Operator Good evening, and welcome to Oyster Point Pharma's Second Quarter 2021 Earnings Conference Call. My name is Justin, and I will be your operator today. [Operator Instructions] At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma's Chief Financial Officer. Please go ahead. Daniel Lochner Good evening, everyone, and welcome to the Oyster Point Pharma Second Quarter Earnings Conference Call for the 3 Months Ending June 30, 2021. This evening, we issued a press release containing our second quarter
For further details see:
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q2 2021 Results - Earnings Call Transcript